|
|
.
NPI Detail
NPI: 1922043744
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
600 XXXXXXXX XXX
MADISON, WI 537920001
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1922043744*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX.XX
|
| 97110
|
THERAPEUTIC EXERCISES
|
XXXXX
|
$XXXXXX.X
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J7190
|
Factor viii
|
XXXXXX
|
$XXXXXX.XX
|
| J0588
|
Incobotulinumtoxin a
|
XXXXXX
|
$XXXXXX.XX
|
| J7210
|
Inj, afstyla, 1 i.u.
|
XXXXXX
|
$XXXXXX.XX
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J0485
|
Belatacept injection
|
XXXXXX
|
$XXXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
| J1447
|
Inj tbo filgrastim 1 microg
|
XXXXX
|
$XXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J2250
|
Inj midazolam hydrochloride
|
XXXXX
|
-
|
| J7192
|
Factor viii recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J3111
|
Inj. romosozumab-aqqg 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J7170
|
Inj., emicizumab-kxwh 0.5 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J1071
|
Inj testosterone cypionate
|
XXXXX
|
-
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J7195
|
Factor ix recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| G1004
|
Cdsm ndsc
|
XXXXX
|
$X.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
